Global Glycated Haemoglobin Testing Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Glycated Haemoglobin Testing Market Research Report 2024
Growing adoption of a sedentary lifestyle and genetic manipulation causes type 1 or type 2 diseases. Globally, more than 400 million adults suffer from diabetes, out of which half of the incidences of diabetes remain undiagnosed.
According to MRAResearch’s new survey, global Glycated Haemoglobin Testing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Glycated Haemoglobin Testing market research.
In recent times there is increased use of glycated haemoglobin testing due to increasing incidence of diabetics among the population. Growing awareness of haemoglobin A1c testing among patients and medical practitioners and aging population are some of the key factors driving the growth for global glycated haemoglobin testing market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Glycated Haemoglobin Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Bio-Rad Laboratories
Bayer
Arkray
Chek Diagnostics
Diazyme Laboratories
X Lite-On Technology
TaiDoc Technology
Trinity Biotech
Siemens Healthcare
Ceragem Medisys
Tosoh Bioscience
DiaSys Diagnostic Systems
Erba Mannheim
Daiichi Biotech
Human Diagnostics
EKF Diagnostics
Mindray Medical
Segment by Type
Lab Based Test
Point-of-care Test
Hospitals
Diagnostic Centers
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Glycated Haemoglobin Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Glycated Haemoglobin Testing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Glycated Haemoglobin Testing market research.
In recent times there is increased use of glycated haemoglobin testing due to increasing incidence of diabetics among the population. Growing awareness of haemoglobin A1c testing among patients and medical practitioners and aging population are some of the key factors driving the growth for global glycated haemoglobin testing market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Glycated Haemoglobin Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bio-Rad Laboratories
Bayer
Arkray
Chek Diagnostics
Diazyme Laboratories
X Lite-On Technology
TaiDoc Technology
Trinity Biotech
Siemens Healthcare
Ceragem Medisys
Tosoh Bioscience
DiaSys Diagnostic Systems
Erba Mannheim
Daiichi Biotech
Human Diagnostics
EKF Diagnostics
Mindray Medical
Segment by Type
Lab Based Test
Point-of-care Test
Segment by Application
Hospitals
Diagnostic Centers
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Glycated Haemoglobin Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source